TZAMAL-MEDICAL GROUP.
http://www.tzamal-medical.co.il/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From TZAMAL-MEDICAL GROUP.
Chinese ADC, RNA Therapy Developers Lead May/June Fundraising
Emerging companies including Bliss Biopharmaceutical, Coherent Biopharma and WestGene Biopharma lifted China biotech funding from May to mid-June.
Deal Terminations Not The End Of The Road For Licensed Drugs
Post-deal termination, approximately 14% of the drugs from those alliances go on to be approved, and of those still in development, nearly two-thirds advance at least one phase. Third in a series of follow-ups to IN VIVO’s 2014 study comparing/contrasting likelihood of approval and up-front payments on alliances, and the outcomes of relevant deals.
Company Information
- Industry
- Distributors
- Medical Devices
- Pharmaceuticals
-
Services
- Group Purchasing
- Home Infusion
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Medical Devices
- Consumables, Central Supplies
- Implantable Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Laser
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Tzamal Bio-Pharma
- Tzamal D-Chem Laboratories
- Tzamal Jakobsohn
- Tzamal-Medical Group
- Tzamal Medicare
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice